1, INTRODUCTION
This study was initiated primarily to discover what use could be made of routine medical records kept in a large general hospital. The Dudley Road Hospital, Birmingham, has for many years maintained a diagnostic index which records the following facts for each discharge or death: diagnosis, age, sex, dates of admissiort and discharge, complications, disposal, and case reference number. Attention was focused on admissions referable to pneumonia because it is one of the commonest reasons for hospital admission, and methods of treatment have changed dramatically during the past 15 years. The inquiry takes within its scope records of two quinquennia, 1934-38 and 1944 48; these were chosen because:
(a) sulphonamide therapy was not yet in general use during the first period; (b) singly or jointly, drugs of the sulphonamide group and antibiotics had become the standard treatment for cases of this sort during the second period. The ensuing study is not in the fullest sense of the term a "clinical trial" since it was not feasible to ensure matching of cases with regard to conditions relevant, or possibly relevant, to treatment efficacy. None the less, it shduld be illuminating if only as a historical review of the treatment of the pneumonia over the last two decades. The historical control (Hill, 1951; Hogben and Wrighton, 1952) has admittedly and rightly been a target of criticism; but it may happen to be the only method of comparison feasible in a field in which ethical as well as practical difficulties beset the theoretically desirable task of subjecting the use of every new drug to a rigorously controlled experiment. Such difficulties are often surmountable when a new drug is available at first only in very small quantities. In such a situation, selection of test cases is inevitable, and the dictates of the ideally controlled clinical trial confront the *Now at the Institute of Psychiatry, University of London, Maudsley Hospital, London. doctor with no dilemma; but the professional code of the physician can accommodate them less congenially if a drug of reputedly life-saving qualities is initially obtainable in adequate supply. However defective the historical method may be, it is still the only one available for assessment of the value of therapies already included in the physician's armamentarium before current standards with regard to the conduct of clinical trials had been accepted; and in that context it has a limited usefulness if applied with judicious recognition of its shortcomings. Its shortcomings are indeed formidable, when the topic involves the infections. Comparison of therapies referable to two eras is open to the particular objection that the virulence of the infecting micro-organisms is known to be variable. Until the advent of the sulphonamides, the annual case mortality from lobar pneumonia varied between 20 and 30 per cent. or an even higher figure (Cecil, 1940) .
Since the introduction of sulphonamide therapy for pneumonia there have been numerous small scale surveys of treated cases, including those of Evans and Gaisford (1938) , Flippin and others (1943) , Kraus (1947) , and Lewis (1948) . In addition, Stahle (1942) (Table I) ; and the differences are too great to be due to chance if we adopt current standards of significance (P<0 -0001). Contrariwise, there was no great reduction of mortality associated with bronchopneumonia. Indeed, in some instances, the mortality rates in the second period were higher than in the 1930s. The only noteworthy exception to the preceding statement is that reduction in the mortality rate for women aged 60 or more was highly significant. and for both lobar and broncho-pneumonia, was very much lower in the period 1944 48 than in 1934-38. The average difference for men suffering from lobar pneumonia was 3 -8 days and for women 6 * 2 days; the difference for males and females suffering from broncho-pneumonia was 5 days. These differences were highly significant, the probability that they would occur in random sampling being less than 1 in 10,000: For men and women over 60 suffering from lobar pneumonia, the difference was not statistically significant. Duration of stay for non-fatal cases of lobar pneumonia with complications fell by almost 50 per cent. in the period here dealt with. For broncho-pneumonia Considerable differences between the age distributions of cases distinguish these two periods (Table V) . In 1944-48, there is a higher proportion of persons in the age groups under 10 and 60 and over, and the differences are highly significant (P<0 0001). Since pneumonia is apt to be more formidable in these age groups, we might expect ceteris paribus more unfavourable results in the second than in the first period.
The incidence of empyema as a complication of lobar pneumonia (Table VI) fell from 4-4 per cent. in the first period to 0 8 per cent. in the second, a highly significant difference. Cecil (1940) cites for pneumococcal pnuemonia treated in the Bellevue Hospital, New York, an empyema incidence of 5-1 per cent. before the introduction of sulphadrugs. In the cases which this survey covers, the incidence of empyema associated with bronchopneumonia was 1 2 per cent. in the earlier group; and there was no case with empyema recorded in the second period. While it is not unreasonable to attribute remarkably favourable results in the second period to the effect of modern therapies including both sulphonamides and anti-biotics, it would not be justifiable to proffer the results of this preliminary study as conclusive evidence to that effect; but the results encouraged the hope that it might well be profitable to bring within the scope of the enquiry more specific information about the relative merits of the several therapies employed. This involved inspection of the individual case records. In view of the additional labour entailed, it was necessary to curtail the size of the sample by dealing only with admissions in the years 1934, 1936, and 1938 (hereafter designated Period A), and 1944, 1946, and 1948 (Period B). (Evans and Gaisford, 1938 All Admissions 953 100-0 768 100*0 1,158 100 0 2,879 100 0 736 100*0 696 100*0 672 100*0 2,104 100-0 had the highest mortality; but such differences are not statistically significant. In each age group the lobar pneumonia case mortality rate was higher for males than for females, but the differences were not large enough to be statistically significant. Table XVII exhibits in greater detail mortality rates for lobar pneumonia in Period B. In each age group, males have a higher mortality rate than females. While none of these differences is large enough to be statistically significant, the trend is consistent. Similarly, we find that the mortality rates among lobar pneumonia cases treated with penicillin are greater than those treated witl suphamezathine for all female age groups and for three out of four male age groups. Again, the differences in each age and sex group are too small to be significant; but the chance of getting seven out of eight results all pointing in the same direction is only 1 in 28, so that these results do suggest that penicillin-treated cases have a higher mortality than sulpha-treated cases. To what extent this may be due to selection of cases it is not possible to tell from the present study.
CONCLUSIONS
From this survey of patients admitted to hospital with lobar pneumonia it is admissible to infer that considerable advantages resulted from the use of sulphonamides and penicillin. In particular, the much lower mortality and empyema rates are challenging; but the shorter duration of stay in hospital is also noteworthy. Even now, many patients do not get full pay while off work on account of sickness, and a saving of several days is therefore of considerable economic benefit to the patient. From the viewpoint of the hospital service, the saving in bed-days is likewise by no means trivial.
If over 300 males and 200 females with lobar pneumonia annually receive treatment in Dudley Road Hospital, then the reduction in duration of stay is expressible as about 2,500 bed-days.
This means setting free, in this one hospital alone in the course of a single year, an average of seven beds for the treatment of other sickness. Presumably, therefore the introduction of modern therapies for pneumonia has greatly increased hospital facilities in England and Wales during the past two decades.
In a study such as this, it is not permissible to adjudicate upon the relative efficacy of the various drugs now used for treatment of the pneumonias.
On the basis of such crude data, it is possible to testify with confidence only to the beneficial effects of the new therapies considered as a whole. With that reservation, the differences between hospital admissions in the 1930s and in the 1940s here demonstrated are so large as to leave little reasonable doubt that they are due to the availability of more efficient treatment in the second period. If one concedes the possibility that the differences might be partly due to changes in the virulence of pneumonia, one would expect that the clinical picture of the pneumonias would also have changed recognizably; but there is no shred of evidence in the data of this or of other studies to support such a contention.
Tentatively, our data tempt us to suggest as a theme for further inquiry the possible differences between the efficacy of sulphonamides and penicillin. They have indeed disclosed a differential response of the sexes to treatment. Thus females, in particular, did not respond so favourably to penicillin as to sulphadrugs; but one must admit the possible existence of a policy of releasing penicillin more freely for male patients, and restricting its allocation for the more seriously ill among females. Unless this is true, and it seems in fact unlikely, one must conclude that females react better to sulphonamides than to penicillin. Again, there may have been a disposition to restrict the prescription of penicillin to serious cases, as may well have been true in 1946; but it is less likely that this was so in 1948 when supplies of penicillin were plentiful. If not, our data give no support to the belief that penicillin-treated cases fare better than sulphonamide-treated patients.
The conclusion last and tentatively stated is of moment vis a vis the cost of treatment: that of a course of sulphamezathine for an average case of pneumonia being 7s. 8d. and that of a course of penicillin being 18s. 1lid. In this connexion it is interesting to cite the results of a clinical trial conducted by the Medical Research Council (1951) to assess three treatments for pneumonia: aureomycin, chloramphenicol, and standard (i.e. penicillin or sulphonamides), alone or in combination, and in whatever dosage the physician prescribed. In fact, only eight cases were found to have had sulphonamides alone. The different treatment groups were similar with respect to sex, age, anatomical location of the infection, day of illness admitted, temperature on admission, and number regarded as desperately ill on admission. The results, judged inter alia by the time taken for temperature to fall or for physical signs to disappear, and by length of stay in hospital, led to the conclusion that:
for clinical pneumonia penicillin is at least as good as aureomycin or chloramphenicol. There are some indications that it may even be better. This report cites the mean cost (as at September, 1951) of treatment with the three antibiotics as £10 ls. 6d. for aureomycin, £8 15s. 1 ld. for chloramphenicol, and 18s. 1 lid. for penicillin. It is clear then that the cost of treatments with closely similar results can vary considerably. While it goes without saying that some patients may respond better, or only, to the more expensive drugs, in which event we are likely to regard the cost as a matter of subsidiary concern, we should be alert to the possibility that greater expense does not necessarily connote greater efficacy, if only because semi-educated public opinion responds all too readily to the appeal of rarity.
5. SuMMARY (1) An assessment is made of the treatment of pneumonias in a large General Hospital by recourse to routine data incorporated in the general diagnostic index and in individual case records of the patients. It covers two quinquennia, one in the 1930s and one in the 1940s.
(2) Analysis of the data referable to over 8,000 patients in the diagnostic index shows that there was a great reduction in:
(a) case mortality of lobar pneumonia; (b) average duration of stay in hospital; (c) incidence of empyema.
(3) A more detailed study based on a smaller sample of individual case records refers to admissions in the years 1934, 1936, 1938, and 1944, 1946, 1948 . Sulphapyridine was the only sulphonamide in use duringthe earlier period, anda comparison of patients treated with it with patients who had no specific treatment discloses a large reduction in case mortality among treated cases. Among the former there was also a higher proportion discharged within 20 days of admission.
(4) In the later period, it is possible to compare results of using sulphonamides and antibiotics. Half the admissions in these three years were treated with sulphamezathine and 30 per cent. with penicillin either alone or in combination with a sulphonamide. In the second period, the progress of patients, as judged by mortality rates, duration of stay, incidence of empyema, and sudden rapid fall of temperature, was consistently much better than that of patients admitted in the 1930s.
(5) On the basis of the three-fold criterion of efficacy adopted, we can detect little difference between males treated with sulphonamides and those treated with penicillin; females seem to react more favourably to sulphonamide treatment than to penicillin.
(6) Reduction in the proportion of cases developing empyema in the second period was accompanied by an increase in the incidence of pleurisy with or without effusion.
(7) Since the introduction of sulphonamides and penicillin for the treatment of the pneumonias, the annual saving of bedspace in the hospital studied is estimated at about 2,500 bed-days, or an average of seven beds throughout the year. 
